RISK WARNING: Your capital is at risk. The risks of investing include: illiquidity; lack of dividends; loss of investment; and dilution. You should invest only as part of a diversified portfolio.
Please read FULL risk warning

DEVELOPING NEW POSSIBILITIES THROUGH PROGRESSIVE RESEARCH

At THAROS™, we are advancing horse health and performance through science-driven innovation. We promote equine health and wellbeing through world-class innovation. Our ground-breaking microbiome research is leading to the development of a number of future products to assist animal health through restored gut function.


Closed

  • Target

    £800,000

  • Type

    Equity

  • Close Date

    Dec 1 2018

  • Status

    Closed

Tharos

NATURE POWERED BY SCIENCE Advancing Horse Health and Performance through Science-driven Innovation

  • Sector: Healthcare
  • Region: UK: South-West
  • Stage: Early Stage - some revenues, pre-profit
  • Eligible Tax: EIS
  • Board Requirement: Board In Place
  • Pre Money Valuation: £2,799,986
  • Share Price: £1.25
  • Originator: Envestors

For information please view deal